Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesAge-specific breast, uterine and ovarian cancer mortality trends in Spain: Changes from 1980 to 2006
Cancer Epidemiology, 10/20/09
Cabanes A et al. – The downturn observed in mortality for these tumors mainly reflects improved survival as a result of earlier diagnosis and better cancer treatments. Cancer management is moving in the right direction in Spain.
Related Articles
Anemia Drugs in Cancer Patients may Cause Thromboembolism
Internet Source, 11/13/09
Relevance Score: 80%
Drugs To Treat Anemia In Cancer Patients Linked To Thromboembolism
ScienceDaily, 11/11/09
Relevance Score: 80%
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Relevance Score: 80%
Stage I breast cancer in a regional oncology practice in Israel 2002-2006: Clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients
The Breast, 10/15/09
Relevance Score: 80%
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 72%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells
Virchows Archiv, 03/22/10
Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells
Cancer Research, 03/22/10
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Cancer Research, 03/22/10
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Presentation and Outcome of Pediatric Ovarian Germ Cell Tumor: A Study of 40 Patients
Journal of Pediatric Hematology/Oncology, 03/22/10
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
Cancer Chemotherapy and Pharmacology, 03/22/10
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
Laboratory Investigation, 03/22/10
Sponsor
Article Search
Sponsor
Sponsor